Elena Ongaro

2.3k total citations
38 papers, 878 citations indexed

About

Elena Ongaro is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Elena Ongaro has authored 38 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Cancer Research. Recurrent topics in Elena Ongaro's work include Colorectal Cancer Treatments and Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer Treatment and Pharmacology (8 papers). Elena Ongaro is often cited by papers focused on Colorectal Cancer Treatments and Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Cancer Treatment and Pharmacology (8 papers). Elena Ongaro collaborates with scholars based in Italy, United States and Germany. Elena Ongaro's co-authors include Giuseppe Aprile, Gianpiero Fasola, Michela Guardascione, Caterina Fontanella, Silvia Bolzonello, Marta Bonotto, Alfredo Falcone, Chiara Cremolini, V. Fanotto and Giovanni Gerardo Cardellino and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Elena Ongaro

35 papers receiving 871 citations

Peers

Elena Ongaro

ONCOL

PRM

PFM

Muhammad Salim United States

Michela Roberto Italy

Ana Custodio Spain

Stratigoula Sakellariou Greece

Sarita Dubey United States

Akitaka Makiyama Japan

Satoshi Yuki Japan

Prachi Patil India

Yuko Sugiyama Japan

Diana Stempak Canada

Muhammad Salim United States

Elena Ongaro

698 ×1.4

ONCOL

250 ×0.8

PRM

260 ×1.0

166 ×1.0

176 ×1.2

PFM

Citations per year, relative to Elena Ongaro Elena Ongaro (= 1×) peers Muhammad Salim

Countries citing papers authored by Elena Ongaro

Since Specialization

Citations

This map shows the geographic impact of Elena Ongaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Ongaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Ongaro more than expected).

Fields of papers citing papers by Elena Ongaro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Ongaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Ongaro. The network helps show where Elena Ongaro may publish in the future.

Co-authorship network of co-authors of Elena Ongaro

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Ongaro. A scholar is included among the top collaborators of Elena Ongaro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Ongaro. Elena Ongaro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nardo, Paola Di, et al.. (2025). Precision oncology in biliary tract cancer: the emerging role of liquid biopsy. ESMO Open. 10(5). 105079–105079. 1 indexed citations

Antoniotti, Carlotta, Federica Marmorino, Daniele Rossini, et al.. (2025). FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials. European Journal of Cancer. 228. 115713–115713.

Nardo, Paola Di, et al.. (2023). Liquid biopsy in colorectal cancer: Onward and upward. Critical Reviews in Oncology/Hematology. 194. 104242–104242. 15 indexed citations

Nardo, Paola Di, Debora Basile, Ana Paula dos Reis Velloso Siciliano, et al.. (2023). Second-line treatment strategies for RAS wild-type colorectal cancer: A systematic review and Network Meta-analysis (NMA). Digestive and Liver Disease. 56(5). 786–794.

Michelotti, A., Luisa Foltran, Michela Guardascione, et al.. (2023). Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives. Critical Reviews in Oncology/Hematology. 186. 104013–104013. 5 indexed citations

Lisanti, C., Debora Basile, Silvio Ken Garattini, et al.. (2022). The SAFFO Study: Sex-Related Prognostic Role and Cut-Off Definition of Monocyte-to-Lymphocyte Ratio (MLR) in Metastatic Colorectal Cancer. Cancers. 15(1). 175–175. 9 indexed citations

Michelotti, A., Michela Guardascione, Rossana Roncato, et al.. (2021). NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. Cells. 10(8). 2034–2034. 29 indexed citations

Garattini, Silvio Ken, Debora Basile, Marta Bonotto, et al.. (2021). Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer. Cancers. 13(14). 3504–3504. 7 indexed citations

Moretto, Roberto, Federica Morano, Elena Ongaro, et al.. (2019). Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component. Clinical Colorectal Cancer. 18(2). 116–124. 7 indexed citations

10.

Garattini, Silvio Ken, Debora Basile, Monica Cattaneo, et al.. (2017). Molecular classifications of gastric cancers: Novel insights and possible future applications. World Journal of Gastrointestinal Oncology. 9(5). 194–194. 45 indexed citations

11.

Bonotto, Marta, Silvio Ken Garattini, Debora Basile, et al.. (2017). Immunotherapy for gastric cancers: emerging role and future perspectives. Expert Review of Clinical Pharmacology. 10(6). 609–619. 30 indexed citations

12.

Ongaro, Elena, M. Cinausero, Riccardo Caccialanza, et al.. (2017). Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer. 20(4). 563–572. 51 indexed citations

13.

Gerratana, Lorenzo, Marta Bonotto, Elena Ongaro, et al.. (2017). Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle. Expert Opinion on Biological Therapy. 17(3). 365–374. 27 indexed citations

14.

Fanotto, V., Elena Ongaro, Karim Rihawi, et al.. (2016). HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget. 7(42). 69060–69074. 26 indexed citations

15.

Puzzoni, Marco, Nicola Silvestris, Francesco Leone, et al.. (2016). The Immune Revolution in Gastrointestinal Tumours: Leading the Way or Just Following?. Targeted Oncology. 11(5). 593–603. 15 indexed citations

16.

Graziano, Francesco, Annamaria Ruzzo, Elisa Giacomini, et al.. (2016). Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer. The Pharmacogenomics Journal. 17(3). 258–264. 86 indexed citations

17.

Vincenzi, Bruno, Chiara Cremolini, Andrea Sartore‐Bianchi, et al.. (2015). Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients. Annals of Oncology. 26. vi38–vi38. 2 indexed citations

18.

Aprile, Giuseppe, Elena Ongaro, Marzia Del Re, et al.. (2015). Angiogenic inhibitors in gastric cancers and gastroesophageal junction carcinomas: A critical insight. Critical Reviews in Oncology/Hematology. 95(2). 165–178. 19 indexed citations

19.

Aprile, Giuseppe, Riccardo Giampieri, Marta Bonotto, et al.. (2014). The challenge of targeted therapies for gastric cancer patients: the beginning of a long journey. Expert Opinion on Investigational Drugs. 23(7). 925–942. 25 indexed citations

20.

Aprile, Giuseppe, Marta Bonotto, Elena Ongaro, Carmelo Pozzo, & Francesco Giuliani. (2013). Critical Appraisal of Ramucirumab (IMC-1121B) for Cancer Treatment: From Benchside to Clinical Use. Drugs. 73(18). 2003–2015. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact